BMRN
Price
$52.98
Change
-$0.78 (-1.45%)
Updated
Sep 25, 03:24 PM (EDT)
Capitalization
10.32B
27 days until earnings call
BOLT
Price
$5.61
Change
-$0.16 (-2.77%)
Updated
Sep 25, 03:14 PM (EDT)
Capitalization
11.08M
Interact to see
Advertisement

BMRN vs BOLT

Header iconBMRN vs BOLT Comparison
Open Charts BMRN vs BOLTBanner chart's image
BioMarin Pharmaceutical
Price$52.98
Change-$0.78 (-1.45%)
Volume$1K
Capitalization10.32B
Bolt Biotherapeutics
Price$5.61
Change-$0.16 (-2.77%)
Volume$400
Capitalization11.08M
BMRN vs BOLT Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. BOLT commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and BOLT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (BMRN: $53.77 vs. BOLT: $5.77)
Brand notoriety: BMRN and BOLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 70% vs. BOLT: 360%
Market capitalization -- BMRN: $10.32B vs. BOLT: $11.08M
BMRN [@Biotechnology] is valued at $10.32B. BOLT’s [@Biotechnology] market capitalization is $11.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileBOLT’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • BOLT’s FA Score: 1 green, 4 red.
According to our system of comparison, BOLT is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 3 TA indicator(s) are bullish while BOLT’s TA Score has 5 bullish TA indicator(s).

  • BMRN’s TA Score: 3 bullish, 6 bearish.
  • BOLT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -1.10% price change this week, while BOLT (@Biotechnology) price change was +7.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +51.82%.

Reported Earning Dates

BMRN is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.3B) has a higher market cap than BOLT($11.1M). BMRN YTD gains are higher at: -18.196 vs. BOLT (-46.085). BMRN has higher annual earnings (EBITDA): 934M vs. BOLT (-51.83M). BMRN has more cash in the bank: 1.43B vs. BOLT (34.8M). BOLT has less debt than BMRN: BOLT (24.2M) vs BMRN (604M). BMRN has higher revenues than BOLT: BMRN (3.06B) vs BOLT (4.17M).
BMRNBOLTBMRN / BOLT
Capitalization10.3B11.1M92,793%
EBITDA934M-51.83M-1,802%
Gain YTD-18.196-46.08539%
P/E Ratio15.86N/A-
Revenue3.06B4.17M73,530%
Total Cash1.43B34.8M4,115%
Total Debt604M24.2M2,496%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
65
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNBOLT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
60%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQST5.420.22
+4.23%
Aquestive Therapeutics
USAC23.770.50
+2.15%
USA Compression Partners LP
VSME2.90-0.02
-0.68%
VS Media Holdings Limited
BSBR5.48-0.08
-1.44%
Banco Santander (Brasil) SA
IFBD1.29-0.06
-4.09%
Infobird Co Ltd

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+0.67%
TECH - BMRN
48%
Loosely correlated
-3.21%
ROIV - BMRN
45%
Loosely correlated
-0.27%
BEAM - BMRN
45%
Loosely correlated
-0.59%
NRIX - BMRN
44%
Loosely correlated
+5.58%
IRON - BMRN
43%
Loosely correlated
+0.37%
More

BOLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with ATXS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+3.96%
ATXS - BOLT
39%
Loosely correlated
-2.42%
XENE - BOLT
38%
Loosely correlated
-1.93%
BMRN - BOLT
36%
Loosely correlated
+0.67%
IOVA - BOLT
35%
Loosely correlated
+2.42%
MGNX - BOLT
35%
Loosely correlated
+3.61%
More